You just read:

SELLAS Receives USAN Approval for Generic Name of Galinpepimut-S for WT1 Vaccine, SELLAS's Late Clinical-Stage Cancer Immunotherapy Candidate

News provided by

SELLAS Life Sciences Group

Mar 29, 2016, 08:00 ET